Wikipedia
Dupilumab
Dupilumab is a monoclonal antibody designed for the treatment of atopic diseases. This drug was developed by Regeneron Pharmaceuticals. The US Food and Drug Administration has designated dupilumab a “ breakthrough therapy” which is designed to speed promising new drugs to market.